NDC 73377-033-01 - Doxycycline Hyclate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73377-033
- Requested NDC
- 73377-033-01
- Package NDCs from labels
- 73377-033-01, 73377-033-02, 73377-033-03
- Manufacturer
- AX Pharmaceutical Corp
- Effective date
- 2026-02-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxycycline Hyclate - AX Pharmaceutical Corp | AX Pharmaceutical Corp | 2026-02-09 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73377-033-01 | Doxycycline Hyclate | 25 kg in 1 DRUM | POWDER | 25 | 7 | |
| 73377-033-02 | Doxycycline Hyclate | 5 kg in 1 DRUM | POWDER | 5 | 7 | |
| 73377-033-03 | Doxycycline Hyclate | 1 kg in 1 DRUM | POWDER | 1 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Proficient Rx LP | e38f3cd2-47e5-438f-bbe3-50b578360f74 | 2024-03-01 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXY 100(TM) DOXYCYCLINE | DOXY 100(TM) DOXYCYCLINE | HF Acquisition Co LLC, DBA HealthFirst | 9454f948-584f-59de-e053-2a95a90a9f01 | 2024-01-30 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Lupin Pharmaceuticals,Inc. | b752ea66-3144-4f78-96fe-a5f4d92740a7 | 2024-01-30 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | NuCare Pharmaceuticals,Inc. | 0fdc3d87-8819-4c2c-e063-6394a90a687b | 2024-01-26 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | e567b431-53fe-4e27-9b05-bf6eeb8abb51 | 2023-12-11 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline | DOXYCYCLINE | Asclemed USA, Inc. | f33ae6f5-bdb6-4c15-9e62-6180433bb1fb | 2023-05-04 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 44ac5de1-c0c6-4d58-9a49-b2dae60ea921 | 2023-04-10 | Warnings, Adverse reactions | 19XTS3T51U |
| DOXYCYCLINE HYCLATE | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 6e587d8d-1a82-4dfa-acea-88704d408f2f | 2023-01-30 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | 24c8472a-dd07-4f84-8bea-20a3f178d119 | 2023-01-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Alembic Pharmaceuticals Limited | ec4535a1-69f0-40a2-bcba-11afc75c721d | 2023-01-27 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline | DOXYCYCLINE | Zydus Lifesciences Limited | 6ae11b4e-1c13-440b-a050-d76e062b0f92 | 2022-11-05 | 19XTS3T51U | |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | dd7672c9-b10f-4ea1-9000-ef3e3faa10db | 2022-09-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE | Proficient Rx LP | e2151005-fb4a-485d-88ad-b44c4594d579 | 2022-06-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 86c1f165-af79-4f01-ab61-3bdbce24cd0d | 2022-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 2993ac3d-0ec4-4230-858e-9fd00063cf57 | 2022-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| doxycycline hyclate | DOXYCYCLINE HYCLATE | Proficient Rx LP | 3303b423-b270-495b-9360-e43144fcf6f2 | 2021-04-01 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxy 100 | DOXYCYCLINE | Fresenius Kabi USA, LLC | b256babb-1bba-4b0c-8837-d13ba3af7659 | 2021-02-17 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxy 100 | DOXYCYCLINE | Fresenius Kabi USA, LLC | a7b754e2-a028-469d-ba95-8412ef03ab0a | 2021-02-02 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxy 100 | DOXYCYCLINE | Fresenius Kabi USA, LLC | b0894010-39bd-459f-8563-cf83343105ee | 2020-06-04 | Warnings, Adverse reactions | 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Sonoma Pharmaceuticals, Inc. | 4fa26176-a730-48ed-9659-e2f64212f418 | 2018-05-23 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.